Hans Peter Hasler insider trades

Open-market stock purchases and sales by Hans Peter Hasler, Director at Gain Therapeutics, Inc, from SEC Form 4 filings since Jul 20, 2016.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -57%.

Recent trades

DateStockTradeValue
Jul 15, 2026GANX Gain Therapeutics, IncBought (not open market)—
Jun 3, 2026NERV Minerva Neurosciences, IncBought (not open market)—
Dec 22, 2025NERV Minerva Neurosciences, IncBought (not open market)—

Companies traded

  • GANX Gain Therapeutics, Inc: other filings, last Jul 15, 2026
  • NERV Minerva Neurosciences, Inc: 1 buy, last Jun 3, 2026
  • PTHN Patheon NV: other filings, last Aug 29, 2017

Get free alerts when Hans Peter Hasler files a new trade →